ArticleFrontiers in nutrition2021

NU9056, a KAT 5 Inhibitor, Treatment Alleviates Brain Dysfunction by Inhibiting NLRP3 Inflammasome Activation, Affecting Gut Microbiota, and Derived Metabolites in LPS-Treated Mice.

Lu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.